Reduction in C-Reactive Protein and Low-Density Lipoprotein Cholesterol and Cardiovascular Event Rates After Initiation of Rosuvastatin: A Prospective Study of the justification for the Use of Statins in Prevention: An Intervention, Trial Evaluating Rosuvastatin Trial

Paul M. Ridker; Eleanor Danielson; Francisco A. H. Fonseca; Jacques Genest; Antonio M. Gotto; John J. P. Kastelein; Wolfgang Koenig; Peter Libby; Alberto J. Lorenzatti; Jean G. Macfadyen; Borge G. Nordestgaard; James Shepherd; James T. Willerson; Robert J. Glynn

doi:https://doi.org/10.1097/01.ogx.0000358018.78512.a1

Reduction in C-Reactive Protein and Low-Density Lipoprotein Cholesterol and Cardiovascular Event Rates After Initiation of Rosuvastatin: A Prospective Study of the justification for the Use of Statins in Prevention: An Intervention, Trial Evaluating Rosuvastatin Trial

Paul M. Ridker, Eleanor Danielson, Francisco A. H. Fonseca, Jacques Genest, Antonio M. Gotto, John J. P. Kastelein, Wolfgang Koenig, Peter Libby, Alberto J. Lorenzatti, Jean G. Macfadyen, Borge G. Nordestgaard, James Shepherd, James T. Willerson, Robert J. Glynn

Research output: Contribution to journal › Editorial › Academic › peer-review

Original language	English
Pages (from-to)	596-597
Journal	Obstetrical & Gynecological Survey
Volume	64
Issue number	9
DOIs	https://doi.org/10.1097/01.ogx.0000358018.78512.a1
Publication status	Published - 2009

Access to Document

https://doi.org/10.1097/01.ogx.0000358018.78512.a1

Cite this

Ridker, P. M., Danielson, E., Fonseca, F. A. H., Genest, J., Gotto, A. M., Kastelein, J. J. P., Koenig, W., Libby, P., Lorenzatti, A. J., Macfadyen, J. G., Nordestgaard, B. G., Shepherd, J., Willerson, J. T., & Glynn, R. J. (2009). Reduction in C-Reactive Protein and Low-Density Lipoprotein Cholesterol and Cardiovascular Event Rates After Initiation of Rosuvastatin: A Prospective Study of the justification for the Use of Statins in Prevention: An Intervention, Trial Evaluating Rosuvastatin Trial. Obstetrical & Gynecological Survey, 64(9), 596-597. https://doi.org/10.1097/01.ogx.0000358018.78512.a1

Ridker, Paul M. ; Danielson, Eleanor ; Fonseca, Francisco A. H. et al. / Reduction in C-Reactive Protein and Low-Density Lipoprotein Cholesterol and Cardiovascular Event Rates After Initiation of Rosuvastatin: A Prospective Study of the justification for the Use of Statins in Prevention: An Intervention, Trial Evaluating Rosuvastatin Trial. In: Obstetrical & Gynecological Survey. 2009 ; Vol. 64, No. 9. pp. 596-597.

@article{c70bf212169a4a558080ad796924547f,

title = "Reduction in C-Reactive Protein and Low-Density Lipoprotein Cholesterol and Cardiovascular Event Rates After Initiation of Rosuvastatin: A Prospective Study of the justification for the Use of Statins in Prevention: An Intervention, Trial Evaluating Rosuvastatin Trial",

author = "Ridker, {Paul M.} and Eleanor Danielson and Fonseca, {Francisco A. H.} and Jacques Genest and Gotto, {Antonio M.} and Kastelein, {John J. P.} and Wolfgang Koenig and Peter Libby and Lorenzatti, {Alberto J.} and Macfadyen, {Jean G.} and Nordestgaard, {Borge G.} and James Shepherd and Willerson, {James T.} and Glynn, {Robert J.}",

year = "2009",

doi = "https://doi.org/10.1097/01.ogx.0000358018.78512.a1",

language = "English",

volume = "64",

pages = "596--597",

journal = "Obstetrical & Gynecological Survey",

issn = "0029-7828",

publisher = "Lippincott Williams and Wilkins",

number = "9",

}

Ridker, PM, Danielson, E, Fonseca, FAH, Genest, J, Gotto, AM, Kastelein, JJP, Koenig, W, Libby, P, Lorenzatti, AJ, Macfadyen, JG, Nordestgaard, BG, Shepherd, J, Willerson, JT & Glynn, RJ 2009, 'Reduction in C-Reactive Protein and Low-Density Lipoprotein Cholesterol and Cardiovascular Event Rates After Initiation of Rosuvastatin: A Prospective Study of the justification for the Use of Statins in Prevention: An Intervention, Trial Evaluating Rosuvastatin Trial', Obstetrical & Gynecological Survey, vol. 64, no. 9, pp. 596-597. https://doi.org/10.1097/01.ogx.0000358018.78512.a1

Reduction in C-Reactive Protein and Low-Density Lipoprotein Cholesterol and Cardiovascular Event Rates After Initiation of Rosuvastatin: A Prospective Study of the justification for the Use of Statins in Prevention: An Intervention, Trial Evaluating Rosuvastatin Trial. / Ridker, Paul M.; Danielson, Eleanor; Fonseca, Francisco A. H. et al.
In: Obstetrical & Gynecological Survey, Vol. 64, No. 9, 2009, p. 596-597.

Research output: Contribution to journal › Editorial › Academic › peer-review

TY - JOUR

T1 - Reduction in C-Reactive Protein and Low-Density Lipoprotein Cholesterol and Cardiovascular Event Rates After Initiation of Rosuvastatin: A Prospective Study of the justification for the Use of Statins in Prevention: An Intervention, Trial Evaluating Rosuvastatin Trial

AU - Ridker, Paul M.

AU - Danielson, Eleanor

AU - Fonseca, Francisco A. H.

AU - Genest, Jacques

AU - Gotto, Antonio M.

AU - Kastelein, John J. P.

AU - Koenig, Wolfgang

AU - Libby, Peter

AU - Lorenzatti, Alberto J.

AU - Macfadyen, Jean G.

AU - Nordestgaard, Borge G.

AU - Shepherd, James

AU - Willerson, James T.

AU - Glynn, Robert J.

PY - 2009

Y1 - 2009

U2 - https://doi.org/10.1097/01.ogx.0000358018.78512.a1

DO - https://doi.org/10.1097/01.ogx.0000358018.78512.a1

M3 - Editorial

SN - 0029-7828

VL - 64

SP - 596

EP - 597

JO - Obstetrical & Gynecological Survey

JF - Obstetrical & Gynecological Survey

IS - 9

ER -

Ridker PM, Danielson E, Fonseca FAH, Genest J, Gotto AM, Kastelein JJP et al. Reduction in C-Reactive Protein and Low-Density Lipoprotein Cholesterol and Cardiovascular Event Rates After Initiation of Rosuvastatin: A Prospective Study of the justification for the Use of Statins in Prevention: An Intervention, Trial Evaluating Rosuvastatin Trial. Obstetrical & Gynecological Survey. 2009;64(9):596-597. doi: https://doi.org/10.1097/01.ogx.0000358018.78512.a1